Patent · US Active

Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof

US10822620B2 · kind B2 · utility

2Cited by
0References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 24, 2019
Grant dateNov 3, 2020
Priority date
Expiry dateApr 24, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2840/203
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides recombinant herpesvirus of turkeys (HVT) vectors that contain and express antigens of avian pathogens, compositions comprising the recombinant HVT vectors and polyvalent vaccines comprising the recombinant HVT vectors. The present invention further provides methods of vaccination against a variety of avian pathogens and method of producing the recombinant HVT vectors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.